Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07MAF
|
||||
| Former ID |
DNC009794
|
||||
| Drug Name |
3-(dimethylamino)-1-(4-heptylphenyl)propan-1-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C18H29NO
|
||||
| Canonical SMILES |
CCCCCCCC1=CC=C(C=C1)C(=O)CCN(C)C
|
||||
| InChI |
1S/C18H29NO/c1-4-5-6-7-8-9-16-10-12-17(13-11-16)18(20)14-15-19(2)3/h10-13H,4-9,14-15H2,1-3H3
|
||||
| InChIKey |
ANCSLKGKDIAGLN-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Thyroid hormone receptor beta-1 | Target Info | Inhibitor | [1] | |
| Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [1] | ||
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Thyroid hormone signaling pathway | |||||
| Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | ||||
| PathWhiz Pathway | Muscle/Heart Contraction | ||||
| Reactome | Nuclear Receptor transcription pathwayR-HSA-1296072:Voltage gated Potassium channels | ||||
| WikiPathways | SIDS Susceptibility Pathways | ||||
| Hematopoietic Stem Cell Differentiation | |||||
| Nuclear ReceptorsWP706:SIDS Susceptibility Pathways | |||||
| Potassium Channels | |||||
| References | |||||
| REF 1 | J Med Chem. 2009 Jul 9;52(13):3892-901.Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.